HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

plafibride (ITA 104)

morpholino-methylurea analog of clofibric acid

Also Known As:

ITA 104; 2-CIMMU; N-(2-(4-chlorophenoxy)isobutyryl)-N-morpholinomethylurea

Networked: 8 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Atherosclerosis 11/01/1983 - "The direct correlation between high circulating lipidic levels and the risk of suffering from atherosclerosis, together with the modification of different lipoproteic fractions in the development of this disease, has led us to study the characteristics of the hypolipemic effect of Plafibride. " 11/01/1983 - "Consequently, Plafibride presents a profile of activity which can be considered suitable in the treatment of atherosclerosis." 11/01/1983 - "Hypolipemic profile of plafibride in a model of experimental atherosclerosis."
2.	Hyperlipoproteinemia Type IV (Type IV, Hyperlipoproteinemia) 05/01/1982 - "[Controlled clinical trial of a new drug (plafibride) for the treatment of hyperlipoproteinemia type IV (author's transl)]." 01/01/1981 - "Double-blind study on the activity of plafibride in the treatment of type IV hyperlipoproteinemia." 01/01/1981 - "The effects of a new drug, N-2-(p-chlorophenoxy)-isobutyryl-N'-morpholinomethylurea (plafibride, ITA 104), were studied in a double blind study lasting four months on a group of 30 patients with a type IV hyperlipoproteinemia. "
3.	Ulcer 11/01/1984 - "[Therapy of ischemic ulcers of the lower extremities using plafibride]."
4.	Hyperlipoproteinemias 01/01/1987 - "Plafibride treatment and serum lipids in hyperlipoproteinemias."
5.	Hyperlipidemias (Hyperlipidemia) 05/19/1984 - "[Plafibride treatment of hyperlipidemias type II and IV]."

Related Drugs and Biologics

1.	plafibride (ITA 104)
2.	Lipids
3.	Clofibrate

Related Therapies and Procedures

1.	Therapeutics